Fig. 2: Dose-response relationship between the categories of percentage body weight change and the percentage of participants meeting or exceeding the MCII threshold for WOMAC function.
From: Loss of body weight is dose-dependently associated with reductions in symptoms of hip osteoarthritis
The linearity test was not adjusted. A P value less than 0.05 signifies a linear dose-response relationship. MCII Minimal clinically important improvement, WOMAC Western Ontario and McMaster Universities Osteoarthritis Index.
